Marshall Fordyce, PRESIDENT AND CEO at Vera Therapeutics, Inc. (VERA), sold 18,500 shares at $37.93 ($702K) on 2026-06-23, disclosed to the SEC on 2026-06-24.
Scheduled sale ($702k) by PRESIDENT AND CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $37.93 | 18,412 | $698K | 99.5% |
| 2 | $38.43 | 88 | $3K | 0.5% |
| Total | $37.93 avg | 18,500 | $702K | 100% |
| Filing → |
| VERA | SELL | 2026-07-09 | $2.0M | — | Filing → |
| VERA | SELL | 2026-05-13 | $680K | — | Filing → |
| VERA | SELL | 2026-04-15 | $1.0M | — | Filing → |